Detalhe da pesquisa
1.
Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.
Am J Hum Genet
; 110(3): 419-426, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868206
2.
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.
J Pathol
; 262(3): 271-288, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38230434
3.
Spatial transcriptomics and the anatomical pathologist: Molecular meets morphology.
Histopathology
; 84(4): 577-586, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991396
4.
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.
J Pathol
; 259(1): 81-92, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36287571
5.
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
J Pathol
; 260(5): 514-532, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608771
6.
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
J Pathol
; 260(5): 498-513, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608772
7.
Predicting response to immune checkpoint blockade in NSCLC with tumour-only RNA-seq.
Br J Cancer
; 128(6): 1148-1154, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572732
8.
Homologous Recombination Repair Deficiency: An Overview for Pathologists.
Mod Pathol
; 36(3): 100049, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788098
9.
Survey of recurrent diagnostic challenges in breast phyllodes tumours.
Histopathology
; 82(1): 95-105, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36468287
10.
Identifying recurrences and metastasis after ductal carcinoma in situ (DCIS) of the breast.
Histopathology
; 82(1): 106-118, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482277
11.
Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast.
Histopathology
; 82(5): 704-712, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36579383
12.
Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.
BMC Cancer
; 23(1): 459, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208678
13.
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing.
Breast Cancer Res Treat
; 191(3): 501-511, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34853987
14.
Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Histopathology
; 81(4): 467-476, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869801
15.
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors.
Lab Invest
; 101(1): 26-37, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873880
16.
Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management.
Histopathology
; 78(5): 759-771, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113154
17.
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
J Pathol
; 250(5): 667-684, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32129476
18.
Emerging entities in NUTM1-rearranged neoplasms.
Genes Chromosomes Cancer
; 59(6): 375-385, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32060986
19.
Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Breast Cancer Res
; 22(1): 91, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32811538
20.
ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling.
Oncologist
; 25(8): 641-649, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32558067